Signal Pharmaceuticals - Ownership and Business Overview

Medical ProductsCompany

Signal Pharmaceuticals Ownership

Who owns Signal Pharmaceuticals?

Signal Pharmaceuticals is owned by Celgene. It was acquired on August 31, 2000.

Signal Pharmaceuticals Business Overview

Where is Signal Pharmaceuticals headquartered?

Signal Pharmaceuticals is headquartered in San Diego, Colorado.

How many employees does Signal Pharmaceuticals have?

Signal Pharmaceuticals has 87 employees.

What sector is Signal Pharmaceuticals in?

Signal Pharmaceuticals is a medical products company.

Medical Products M&A Summary in 2000

Out of 60 sectors in the Mergr database, medical products ranked 13 in number of deals in 2000. The largest medical products acquisition in 2000 was InnerDyne - which was acquired by Tyco International for $180M.

Join Mergr to view all 41 acquisitions of medical products companies in 2000, including 12 acquisitions by private equity firms, and 29 by strategics.

Signal Pharmaceuticals, Inc.

4550 Towne Centre Court,
San Diego, Colorado 92121
United States,
(858)558-7500

Signal Pharmaceuticals, Inc., a privately held San Diego-based biopharmaceutical company focused on the discovery and development of new classes of drugs that regulate genes associated with disease. Signal's technology is centered in the key areas of intracellular signaling and gene and protein regulation.


 Subscribe to unlock this and 206,393
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.